<DOC>
	<DOCNO>NCT01314625</DOCNO>
	<brief_summary>The purpose study determine whether orthostatic hypotension report among subject bortezomib-containing regimen cause dysfunction autonomic nervous system ( ANS ) .</brief_summary>
	<brief_title>A Study Evaluating Hypotension Autonomic Nervous System Dysfunction Multiple Myeloma ( MM ) Patients</brief_title>
	<detailed_description>1 . To gather pilot data incidence autonomic dysfunction patient Multiple Myeloma prior treatment Bortezomib . 2 . To characterize change ANS include fluctuation blood pressure ( hypotension /hypertension ) associate bortezomib . 3 . To determine duration ANS dysfunction present . This treatment study , evaluation autonomic nervous system ( ANS ) among subject receive antimyeloma therapy include bortezomib ( Velcade ) .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<criteria>Subjects Active Multiple Myeloma schedule treat Bortezomibcontaining regimen . Subjects must sign IRBapproved informed consent indicate understand propose treatment understand protocol approve IRB . Subjects unstable cardiovascular disease . Recent ( &lt; 6 month ) myocardial infarction , unstable angina , difficult control congestive heart failure , uncontrolled hypertension , difficult control cardiac arrhythmia . Subjects unable perform Valsalva maneuver patient clinically significant aortic stenosis , glaucoma retinopathy . Subjects receive Selective Serotonin Reuptake Inhibitors .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>